The Classic Kid vs The Tricky One
Classic Kawasaki is straightforward: fever persisting ≥5 days plus at least 4 of the 5 principal clinical features: bilateral nonexudative conjunctival injection, oral mucosal changes (strawberry tongue, cracked lips), polymorphous rash, extremity changes (edema, erythema, desquamation), and cervical lymphadenopathy (≥1.5 cm, usually unilateral).
But a quarter to a third of kids do not fit the classic presentation. Young infants especially may have only 3 criteria yet have full-blown Kawasaki with coronary involvement. Missing these kids results in giant aneurysms.
Incomplete presentations are challenging. A febrile toddler with only 3 criteria on day 6 of fever could represent Kawasaki. If you choose not to treat and it is Kawasaki, you risk coronary complications. If you treat and it is not Kawasaki, you expose them to IVIG unnecessarily. Use the Kawasaki Diagnostic Criteria tool to work through the incomplete cases systematically.
How to Diagnose It
Classic Kawasaki: Fever ≥5 days plus at least 4 of the 5 principal features (conjunctivitis, oral changes, rash, extremity changes, lymphadenopathy). Note that experienced clinicians may diagnose Kawasaki before day 5 of fever if the clinical picture is classic.
Incomplete Kawasaki requires laboratory support. Look for CRP >3 mg/dL or ESR >40 mm/hr, which represents more severe inflammation than typical viral illness. Thrombocytosis (platelets >450k), anemia, and elevated liver enzymes all increase the probability. Importantly, if an early echocardiogram shows a coronary z-score >2.0 in a febrile child with only 3 clinical criteria, Kawasaki disease must be presumed until proven otherwise.
Before initiating IVIG, rule out other etiologies: scarlet fever (sandpaper rash, positive strep culture), measles (cough, Koplik spots), and drug reactions, which can mimic Kawasaki. However, if alternative diagnoses are excluded and laboratory markers are markedly elevated, treatment should not be delayed.
Risk Stratification: Kobayashi Score
About 10-15% of Kawasaki kids don't respond to IVIG, they keep spiking fevers. Those are the ones who get coronary aneurysms. So why wait for them to fail?
The Kobayashi score predicts IVIG resistance at presentation. It uses seven weighted variables: serum sodium ≤133 mmol/L (2 points), illness day at initial treatment ≤4 (2 points), AST ≥100 IU/L (2 points), neutrophils ≥80% (2 points), CRP ≥10 mg/dL (1 point), age ≤12 months (1 point), and platelet count ≤300,000/μL (1 point). A total score ≥5 points predicts IVIG resistance with approximately 76% sensitivity. For high-risk patients, consider adding infliximab or corticosteroids upfront with IVIG.
Use the Kobayashi Score calculator before you give your first dose.
Coronary Assessment
The Coronary Z-Score calculator normalizes coronary artery dimensions to BSA and enables objective classification per AHA guidelines. Stratification is as follows:
- Z < 2.0: No coronary involvement. Low-dose aspirin for 4–6 weeks, standard echo follow-up.
- Z = 2.0 to <2.5 (dilation only): Transient dilation without aneurysm. Low-dose aspirin, close surveillance. Most normalize within 4–8 weeks.
- Z = 2.5 to <5.0 (small aneurysm): Low-dose aspirin as antiplatelet therapy. Serial imaging every 6–12 months. No anticoagulation needed at this level.
- Z = 5.0 to <10.0 (medium aneurysm): Antiplatelet therapy (aspirin) PLUS anticoagulation (warfarin with target INR 2.0–3.0, or low-molecular-weight heparin). Regular echocardiographic surveillance.
- Z ≥ 10.0 (giant aneurysm): Dual antiplatelet therapy (aspirin + clopidogrel) PLUS anticoagulation. Cardiac catheterization to assess for stenosis or thrombus. Lifelong cardiology follow-up.
Long-Term Follow-Up Strategy
Long-term management follows the AHA 2017 risk stratification based on maximal coronary artery z-scores. The Coronary Classification tool sorts patients into 5 risk levels:
- Risk Level I (No involvement, z always <2.0): Low-dose aspirin for 4–6 weeks from diagnosis, then discontinue. No long-term follow-up needed beyond routine pediatric care. No activity restrictions.
- Risk Level II (Dilation only, z 2.0–<2.5 that resolves within 8 weeks): Low-dose aspirin until normalization is documented. Cardiology follow-up at 1 year, then every 3–5 years.
- Risk Level III (Small aneurysm, z 2.5–<5.0): Low-dose aspirin indefinitely. Echocardiography every 6–12 months. Activity counseling; avoid contact sports with anticoagulation.
- Risk Level IV (Medium aneurysm, z 5.0–<10.0, or multiple small aneurysms): Aspirin plus anticoagulation (warfarin or LMWH). Serial echoes every 4–6 months. Stress testing when age-appropriate. Activity restrictions per cardiology.
- Risk Level V (Giant aneurysm, z ≥10.0): Dual antiplatelet plus anticoagulation, lifelong. Periodic cardiac catheterization for stenosis or thrombus. Some will require coronary intervention or bypass surgery. Lifelong cardiology follow-up is mandatory.
Initial Treatment
IVIG should be administered within the first 10 days of illness, ideally by day 5–7 of fever. Standard dose is 2 g/kg as a single infusion over 10–12 hours. Aspirin dosing practices vary: some centers use high-dose aspirin (80–100 mg/kg/day divided into 4 doses) during the acute phase, while others use moderate-dose (30–50 mg/kg/day). After fever resolution, transition to low-dose aspirin (3–5 mg/kg/day) for antiplatelet effect, continued for at least 6–8 weeks or until coronary arteries are confirmed normal.
The Kobayashi score might push you to add infliximab or high-dose corticosteroids upfront rather than waiting for the kid to fail IVIG. The literature increasingly supports this, it cuts down on resistance and coronary complications.
When IVIG Doesn't Work
Persistent fever more than 36 hours after IVIG administration defines IVIG resistance. Administer a second IVIG dose and strongly consider infliximab. Watchful waiting is not recommended.
Echo at diagnosis, again at 2 weeks, and once more at 8 weeks. That sequence tells you whether coronary involvement is evolving. If the kid resists IVIG or has coronary changes, echo earlier and more often.
The clinical priorities are to diagnose incomplete Kawasaki before day 10 of fever, apply risk stratification with Kobayashi score at presentation, initiate IVIG with adjunctive therapy as appropriate, and use coronary z-scores to guide long-term anticoagulation strategy. Missing this diagnosis results in significant risk of myocardial infarction in adolescence or adulthood.